FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Imig

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Phenomena

Renal Circulation

Physiology

Microcirculation

Co-author Network

Publications

TOP 3
John D Imig; Tasuku Nagasawa; Sean M Shaw; Katie A Walsh; Mary Cherian-Shaw; Md Abdul Hye Khan; Bruce D Hammock
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
Tasuku Nagasawa; Md Abdul Hye Khan; John D Imig
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.
Ishfaq A Bukhari; John R Falck; Kathryn M Gauthier; John D Imig; Sreenivasulu Reddy Koduru; Abdul Jabbar Shah; Katherine A Walsh; William B Campbell
11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Imig (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: John D Imig; Tasuku Nagasawa; Sean M Shaw; Katie A Walsh; Mary Cherian-Shaw; Md Abdul Hye Khan; Bruce D Hammock
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
Experimental biology and medicine (Maywood, N.J.) 2012;237(12):1402-12.
2012: Tasuku Nagasawa; Md Abdul Hye Khan; John D Imig
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.
Clinical and experimental pharmacology & physiology 2012;39(5):454-61.
2012: Ishfaq A Bukhari; John R Falck; Kathryn M Gauthier; John D Imig; Sreenivasulu Reddy Koduru; Abdul Jabbar Shah; Katherine A Walsh; William B Campbell
11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.
American journal of physiology. Heart and circulatory physiology 2012;302(8):H1574-83.
2011: Ahmed A Elmarakby; Jessica Faulkner; Krishna Rao Maddipati; Mong-Heng Wang; Mohamed Al-Shabrawey; John D Imig
Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
American journal of physiology. Regulatory, integrative and comparative physiology 2011;301(5):R1307-17.
2011: Kathryn M Gauthier; David D Gutterman; Adam Harder; John D Imig; Marilyn Isbell; Lauren Olson; John R Falck; William B Campbell
Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
American journal of physiology. Renal physiology 2011;301(4):F765-72.
2011: Abdul Hye Khan; John D Imig
Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
American journal of hypertension 2011;24(7):816-21.
2010: John D Imig
20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertension.
Hypertension 2010;56(5):822-3.
2010: John D Imig
Targeting epoxides for organ damage in hypertension.
Journal of cardiovascular pharmacology 2010;56(4):329-35.
2010: A N Simpkins; Radu Daniel Rudic; S Roy; H J Tsai; Bruce D Hammock; John D Imig
Soluble epoxide hydrolase inhibition modulates vascular remodeling.
American journal of physiology. Heart and circulatory physiology 2010;298(3):H795-806.
2010: Ahmed A Elmarakby; John D Imig
Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.
Clinical science (London, England : 1979) 2010;118(4):291-301.
2010: John D Imig; Ahmed A Elmarakby; Kasem Nithipatikom; Shouzou Wei; Jorge H Capdevila; Venugopal Raju Tuniki; Bhavani Sangras; Siddam Anjaiah; Vijaya L Manthati; D Sudarshan Reddy; John R Falck
Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions.
Frontiers in physiology 2010;1():157.
2010: Tengis S Pavlov; John D Imig; Alexander Staruschenko
Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors.
PPAR research 2010;2010():703735.
2010: V Sudhahar; S Shaw; John D Imig
Epoxyeicosatrienoic acid analogs and vascular function.
Current medicinal chemistry 2010;17(12):1181-90.
2010: Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.
American journal of physiology. Renal physiology 2010;298(1):F86-94.
2009: John D Imig; Bruce D Hammock
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.
Nature reviews. Drug discovery 2009;8(10):794-805.
2009: Marlina Manhiani; Jeffrey E Quigley; Sarah F Knight; Shiva Tasoobshirazi; TarRhonda Moore; Michael W Brands; Bruce D Hammock; John D Imig
Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
American journal of physiology. Renal physiology 2009;297(3):F740-8.
2009: Jeffrey E Quigley; Ahmed A Elmarakby; Sarah F Knight; Marlina M Manhiani; David W Stepp; Jeffrey J Olearzcyk; John D Imig
Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
Clinical and experimental pharmacology & physiology 2009;36(7):724-8.
2009: Alexis N Simpkins; Radu Daniel Rudic; Derek A Schreihofer; Sid Roy; Marlina Manhiani; Hsing-Ju Tsai; Bruce D Hammock; John D Imig
Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
The American journal of pathology 2009;174(6):2086-95.
2009: Varadarajan Sudhahar; Sean Shaw; John D Imig
Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
European journal of pharmacology 2009;607(1-3):143-50.
2009: Jeffrey J Olearczyk; Jeffrey E Quigley; Bradford C Mitchell; Tatsuo Yamamoto; In-Hae Kim; John William Newman; Ayala Luria; Bruce D Hammock; John D Imig
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
Clinical science (London, England : 1979) 2009;116(1):61-70.
2008: Neveen Said; Ahmed A Elmarakby; John D Imig; David J Fulton; Kouros Motamed
SPARC ameliorates ovarian cancer-associated inflammation.
Neoplasia (New York, N.Y.) 2008;10(10):1092-104.
2008: John D Imig; Christiana Dimitropoulou; D Sudarshan Reddy; Richard E White; John R Falck
Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.
Microcirculation (New York, N.Y. : 1994) 2008;15(2):137-50.
2008: John D Imig
Eicosanoids and renal damage in cardiometabolic syndrome.
Expert opinion on drug metabolism & toxicology 2008;4(2):165-74.
2008: Sarah F Knight; Jeffrey E Quigley; Jianghe Yuan; Siddhartha S Roy; Ahmed A Elmarakby; John D Imig
Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet.
Hypertension 2008;51(2):352-9.
2008: Ahmed A Elmarakby; Jeffrey E Quigley; John D Imig; Jennifer Pollock; David M Pollock
TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2008;294(1):R76-83.
2007: Ahmed A Elmarakby; Jeffrey E Quigley; Jeffrey J Olearczyk; Aarthi Sridhar; Anthony K Cook; Edward Inscho; David M Pollock; John D Imig
Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.
Hypertension 2007;50(6):1069-76.
2007: Neveen Said; Matthew J Socha; Jeffrey J Olearczyk; Ahmed A Elmarakby; John D Imig; Kouros Motamed
Normalization of the ovarian cancer microenvironment by SPARC.
Molecular cancer research : MCR 2007;5(10):1015-30.
2007: Matthew J Socha; Marlina Manhiani; Neveen Said; John D Imig; Kouros Motamed
Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension.
The American journal of pathology 2007;171(4):1104-12.
2007: Sarah F Knight; John D Imig
Obesity, insulin resistance, and renal function.
Microcirculation (New York, N.Y. : 1994) 2007;14(4-5):349-62.
2007: Kyu-Tae Kang; Jennifer C Sullivan; Jennifer M Sasser; John D Imig; Jennifer Pollock
Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats.
Hypertension 2007;49(4):893-901.
2007: Christiana Dimitropoulou; Lashondra West; Mary B Field; Richard E White; L Manmohan Reddy; John R Falck; John D Imig
Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation.
Prostaglandins & other lipid mediators 2007;83(1-2):50-61.
2007: Ahmed A Elmarakby; Jan M Williams; John D Imig; Jennifer Pollock; David M Pollock
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Vascular pharmacology 2007;46(2):144-51.
2007: Marlina Manhiani; Jeffrey E Quigley; Matthew J Socha; Kouros Motamed; John D Imig
IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension.
Kidney & blood pressure research 2007;30(4):195-202.
2006: Jeffrey J Olearczyk; Mary B Field; In-Hae Kim; Christophe Morisseau; Bruce D Hammock; John D Imig
Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
The Journal of pharmacology and experimental therapeutics 2006;318(3):1307-14.
2006: John D Imig
Eicosanoids and renal vascular function in diseases.
Clinical science (London, England : 1979) 2006;111(1):21-34.
2006: Liming Jin; Zhekang Ying; Rob H P Hilgers; Jia Yin; Xueying _ Zhao; John D Imig; R Clinton Webb
Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats.
The Journal of pharmacology and experimental therapeutics 2006;318(1):288-95.
2006: Xueying _ Zhao; Jeffrey E Quigley; Jianghe Yuan; Mong-Heng Wang; Yiqing Zhou; John D Imig
PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats.
American journal of physiology. Heart and circulatory physiology 2006;290(6):H2187-95.
2006: Ahmed A Elmarakby; Jeffrey E Quigley; David M Pollock; John D Imig
Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension.
Hypertension 2006;47(3):557-62.
2006: Liming Jin; Clare E Foss; Xueying _ Zhao; Thomas M Mills; Mong-Heng Wang; Lynnette McCluskey; Ganesh S S Yaddanapud; John R Falck; John D Imig; R Clinton Webb
Cytochrome P450 epoxygenases provide a novel mechanism for penile erection.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(3):539-41.
2006: Dexter L Lee; Lashon C Sturgis; Hicham Labazi; James B Osborne; Cassandra Fleming; Jennifer Pollock; Marlina Manhiani; John D Imig; Michael W Brands
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.
American journal of physiology. Heart and circulatory physiology 2006;290(3):H935-40.
2006: John D Imig
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
Cardiovascular drug reviews 2006;24(2):169-88.
2005: Anne M Dorrance; Nicole Rupp; David M Pollock; John William Newman; Bruce D Hammock; John D Imig
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 2005;46(6):842-8.
2005: Edward Inscho; John D Imig; Anthony K Cook; David M Pollock
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin.
British journal of pharmacology 2005;146(7):1019-26.
2005: John D Imig; Xueying _ Zhao; Constantine Z Zaharis; Jeffrey J Olearczyk; David M Pollock; John William Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
Hypertension 2005;46(4):975-81.
2005: Xueying _ Zhao; Anthony K Cook; Mary Field; Brentan Edwards; Shali Zhang; Zhanying Zhang; Jennifer Pollock; John D Imig; Edward Inscho
Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
Hypertension 2005;46(3):562-8.
2005: John D Imig
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.
American journal of physiology. Renal physiology 2005;289(3):F496-503.
2005: Jan Michael Williams; Xueying _ Zhao; Mong-Heng Wang; John D Imig; David M Pollock
Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade.
Hypertension 2005;46(2):366-71.
2005: David M Pollock; John M Jenkins; Anthony K Cook; John D Imig; Edward Inscho
L-type calcium channels in the renal microcirculatory response to endothelin.
American journal of physiology. Renal physiology 2005;288(4):F771-7.
2005: John D Imig; Xueying _ Zhao; Aparajita Dey; Marsha Shaw
CYP450, COX-2 and Obesity Related Renal Damage.
Toxicology mechanisms and methods 2005;15(2):125-36.
2005: Xueying _ Zhao; Aparajita Dey; Olga P Romanko; David W Stepp; Mong-Heng Wang; Yiqing Zhou; Liming Jin; Jennifer Pollock; R Clinton Webb; John D Imig
Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2005;288(1):R188-96.
2004: Xueying _ Zhao; John R Falck; Renju Gopal; Edward Inscho; John D Imig
P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid.
The Journal of pharmacology and experimental therapeutics 2004;311(3):1211-7.
2004: Aparajita Dey; Christine Maric; Wayne H Kaesemeyer; Constantine Z Zaharis; Janet Stewart; Jennifer Pollock; John D Imig
Rofecoxib decreases renal injury in obese Zucker rats.
Clinical science (London, England : 1979) 2004;107(6):561-70.
2004: Jennifer C Sullivan; E Dabbs Loomis; Matthew Collins; John D Imig; Edward Inscho; Jennifer Pollock
Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats.
Journal of applied physiology (Bethesda, Md. : 1985) 2004;97(4):1268-74.
2004: Aparajita Dey; Roger S Williams; David M Pollock; David W Stepp; John William Newman; Bruce D Hammock; John D Imig
Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.
Obesity research 2004;12(8):1278-89.
2004: Edward Inscho; Anthony K Cook; John D Imig; C Vial; R J Evans
Renal autoregulation in P2X1 knockout mice.
Acta physiologica Scandinavica 2004;181(4):445-53.
2004: Xueying _ Zhao; Tatsuo Yamamoto; John William Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock; Janet Stewart; Jennifer Pollock; David M Pollock; John D Imig
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
Journal of the American Society of Nephrology : JASN 2004;15(5):1244-53.
2004: Edward Inscho; Anthony K Cook; James B Murzynowski; John D Imig
Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation.
Journal of hypertension 2004;22(4):811-8.
2003: Edward Inscho; Anthony K Cook; John D Imig; Catherine Vial; Richard J Evans
Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior.
The Journal of clinical investigation 2003;112(12):1895-905.
2003: Shih Shen Yiu; Xueying _ Zhao; Edward Inscho; John D Imig
12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels.
Journal of lipid research 2003;44(12):2391-9.
2003: Mong-Heng Wang; Anita Smith; Yiqiang Zhou; Hsin-Hsin Chang; Songbai Lin; Xueying _ Zhao; John D Imig; Anne M Dorrance
Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension.
Hypertension 2003;42(4):594-9.
2003: Xueying _ Zhao; David M Pollock; Darryl C Zeldin; John D Imig
Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases.
Hypertension 2003;42(4):775-80.
2003: John D Imig; Xueying _ Zhao; Sheyla R Orengo; Susana Dipp; Samir S El-Dahr
The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin.
Peptides 2003;24(8):1141-7.
2003: Xueying _ Zhao; David M Pollock; Edward Inscho; Darryl C Zeldin; John D Imig
Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension.
Hypertension 2003;41(3 Pt 2):709-14.
2002: John D Imig; Matthew D Breyer; Richard M Breyer
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice.
American journal of physiology. Renal physiology 2002;283(3):F415-22.
2002: Lisa M Harrison-Bernard; John D Imig; Pamela K Carmines
Renal AT1 receptor protein expression during the early stage of diabetes mellitus.
International journal of experimental diabetes research 2002;3(2):97-108.
2002: John D Imig; Xueying _ Zhao; Jorge H Capdevila; Christophe Morisseau; Bruce D Hammock
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.
Hypertension 2002;39(2 Pt 2):690-4.
2002: John D Imig; Edward Inscho
Adaptations of the renal microcirculation to hypertension.
Microcirculation (New York, N.Y. : 1994) 2002;9(4):315-28.
2002: Jia L Zhuo; John D Imig; Timothy G Hammond; Sheyla Orengo; Edmund Benes; L Gabriel Navar
Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor.
Hypertension 2002;39(1):116-21.
2001: Xueying _ Zhao; Edward Inscho; M Bondlela; JR Falck; John D Imig
The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction.
American journal of physiology. Heart and circulatory physiology 2001;281(5):H2089-96.
2001: S M White; John D Imig; T T Kim; B C Hauschild; Edward Inscho
Calcium signaling pathways utilized by P2X receptors in freshly isolated preglomerular MVSMC.
American journal of physiology. Renal physiology 2001;280(6):F1054-61.
2001: John D Imig; JR Falck; S Wei; J H Capdevila
Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin.
Journal of vascular research 2001;38(3):247-55.
2001: John D Imig; Xueying _ Zhao; JR Falck; S Wei; J H Capdevila
Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid.
Journal of hypertension 2001;19(5):983-92.
2001: John D Imig; L Gabriel Navar
Measurement of Renal Tubular Angiotensin II.
Methods in molecular medicine 2001;51():427-34.
2000: John D Imig
Eicosanoid regulation of the renal vasculature.
American journal of physiology. Renal physiology 2000;279(6):F965-81.
2000: John D Imig
Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension.
American journal of hypertension 2000;13(7):810-8.
2000: John D Imig; Anthony K Cook; Edward Inscho
Postglomerular vasoconstriction to angiotensin II and norepinephrine depends on intracellular calcium release.
General pharmacology 2000;34(6):409-15.
2000: L Gabriel Navar; A Ichihara; So Yeon Chin; John D Imig
Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension.
Acta physiologica Scandinavica 2000;168(1):139-47.
2000: L Gabriel Navar; Lisa M Harrison-Bernard; John D Imig; Ludek Cervenka; Kenneth D Mitchell
Renal responses to AT1 receptor blockade.
American journal of hypertension 2000;13(1 Pt 2):45S-54S.
2000: John D Imig; BT Pham; EA LeBlanc; K M Reddy; JR Falck; Edward Inscho
Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses.
Hypertension 2000;35(1 Pt 2):307-12.
2000: A C Schroeder; John D Imig; EA LeBlanc; BT Pham; David M Pollock; Edward Inscho
Endothelin-mediated calcium signaling in preglomerular smooth muscle cells.
Hypertension 2000;35(1 Pt 2):280-6.
1999: A Ichihara; John D Imig; L Gabriel Navar
Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure.
Hypertension 1999;34(4 Pt 2):843-7.
1999: Ludek Cervenka; Lisa M Harrison-Bernard; Susana Dipp; G Primrose; John D Imig; Samir S El-Dahr
Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice.
Hypertension 1999;34(2):176-80.
1999: John D Imig; GL Navar; LX Zou; K C O'Reilly; Patricia L Allen; JH Kaysen; Timothy G Hammond; L Gabriel Navar
Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors.
The American journal of physiology 1999;277(2 Pt 2):F303-11.
1999: John D Imig; JR Falck; Edward Inscho
Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness.
British journal of pharmacology 1999;127(6):1399-405.
1999: L Gabriel Navar; Lisa M Harrison-Bernard; John D Imig; Chi-Tarng Wang; Ludek Cervenka; Kenneth D Mitchell
Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
Journal of the American Society of Nephrology : JASN 1999;10 Suppl 12():S266-72.
1999: Edward Inscho; A C Schroeder; PC Deichmann; John D Imig
ATP-mediated Ca2+ signaling in preglomerular smooth muscle cells.
The American journal of physiology 1999;276(3 Pt 2):F450-6.
1999: John D Imig
Epoxyeicosatrienoic acids. Biosynthesis, regulation, and actions.
Methods in molecular biology (Clifton, N.J.) 1999;120():173-92.
1999: A Ichihara; John D Imig; L Gabriel Navar
Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension.
Hypertension 1999;33(1 Pt 2):462-6.
1999: John D Imig; Edward Inscho; PC Deichmann; K M Reddy; JR Falck
Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A.
Hypertension 1999;33(1 Pt 2):408-13.
1999: Edward Inscho; EA LeBlanc; BT Pham; S M White; John D Imig
Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells.
Hypertension 1999;33(1 Pt 2):195-200.
1999: Edward Inscho; John D Imig; PC Deichmann; Anthony K Cook
Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
Journal of the American Society of Nephrology : JASN 1999;10 Suppl 11():S178-83.
1998: A Ichihara; John D Imig; Edward Inscho; L Gabriel Navar
Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS.
The American journal of physiology 1998;275(4 Pt 2):F605-12.
1998: L Gabriel Navar; Edward Inscho; John D Imig; Kenneth D Mitchell
Heterogeneous activation mechanisms in the renal microvasculature.
Kidney international. Supplement 1998;67():S17-21.
1998: A Ichihara; John D Imig; Edward Inscho; L Gabriel Navar
Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension.
Hypertension 1998;31(6):1255-60.
1998: LX Zou; John D Imig; A Hymel; L Gabriel Navar
Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor.
American journal of hypertension 1998;11(5):570-8.
1998: A Ichihara; Edward Inscho; John D Imig; L Gabriel Navar
Neuronal nitric oxide synthase modulates rat renal microvascular function.
The American journal of physiology 1998;274(3 Pt 2):F516-24.
1998: Edward Inscho; Anthony K Cook; V Mui; John D Imig
Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction.
Hypertension 1998;31(1 Pt 2):421-8.
1997: L Gabriel Navar; John D Imig; L Zou; Chi-Tarng Wang
Intrarenal production of angiotensin II.
Seminars in nephrology 1997;17(5):412-22.
1997: John D Imig; PC Deichmann
Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways.
The American journal of physiology 1997;273(2 Pt 2):F274-82.
1997: Edward Inscho; MJ Mason; A C Schroeder; PC Deichmann; K D Stiegler; John D Imig
Agonist-induced calcium regulation in freshly isolated renal microvascular smooth muscle cells.
Journal of the American Society of Nephrology : JASN 1997;8(4):569-79.
1997: Alan D Kaye; Bobby D Nossaman; DE Smith; Ikhlass N Ibrahim; John D Imig; Philip J Kadowitz
Effects of phospholipase A2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed.
The American journal of physiology 1997;272(4 Pt 1):L573-9.
1997: A Ichihara; Edward Inscho; John D Imig; R E Michel; L Gabriel Navar
Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension.
Hypertension 1997;29(1 Pt 2):442-9.
1997: Edward Inscho; John D Imig; Anthony K Cook
Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores.
Hypertension 1997;29(1 Pt 2):222-7.
1996: John D Imig; L Gabriel Navar; R J Roman; K K Reddy; JR Falck
Actions of epoxygenase metabolites on the preglomerular vasculature.
Journal of the American Society of Nephrology : JASN 1996;7(11):2364-70.
1996: L X Zou; John D Imig; A M von Thun; A Hymel; H Ono; L Gabriel Navar
Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats.
Hypertension 1996;28(4):669-77.
1996: John D Imig; L Gabriel Navar
Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways.
The American journal of physiology 1996;271(1 Pt 2):F87-93.
1996: L Gabriel Navar; Edward Inscho; S A Majid; John D Imig; Lisa M Harrison-Bernard; Kenneth D Mitchell
Paracrine regulation of the renal microcirculation.
Physiological reviews 1996;76(2):425-536.
1996: L X Zou; A Hymel; John D Imig; L Gabriel Navar
Renal accumulation of circulating angiotensin II in angiotensin II-infused rats.
Hypertension 1996;27(3 Pt 2):658-62.